R

Roche

Global pharmaceuticals and diagnostics company

Lifecycle Leader - Ophthalmology

Corporate StrategyConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • A Bachelor's degree is required; a marketing, business management, or life sciences discipline is preferred.
  • Demonstrable prior accomplishments developing and overseeing breakthrough development and/or commercial strategies that produced considerable financial results.
  • Product management and product launch experience.
  • Ability to rapidly understand and navigate technical, supply, development, and regulatory challenges, with a deep understanding of global health systems and access and reimbursement challenges.
  • A proven track record in building teams and influencing in a cross-functional environment.
  • Exceptional strategic orientation and agility, ability to develop a long-term vision, and deep understanding of the global pharmaceutical and biotechnology industry to create robust and innovative business strategies.
  • Exceptional ability to synthesize and summarize strategic concepts in ambiguous contexts and deliver key milestones, product targets, and lifecycle value.
  • Proven ability to collaborate end-to-end across early- to late-stage development and cross-functionally within the Ophthalmology portfolio and broader enterprise.

Responsibilities

  • Shape the long-term vision and strategy for one or several large and/or complex asset programs in partnership with early development, Pharma Development, Global Pharma Strategy, Pharma Development Medical Affairs leads, and external partners.
  • Contribute earlier in the lifecycle to create a seamless transition from early to late stage, including providing input to the asset team at critical points such as a pivotal enabling Clinical Development Plan.
  • Support relevant early development asset teams, licensing, and other business development activities.
  • Drive alignment and integrated decision-making with Global Development, Global Technical, and Commercial Leadership teams to realize asset potential within asset, disease-area, and therapeutic-area strategies.
  • Drive an asset, disease-area, and enterprise mindset and team capability development in line with OnePharmaStrategy.
  • Align people around a vision and foster accountability, collaboration, inclusion, and trust.
  • Serve as a thought partner and sounding board for Global Pharma Strategy and cross-organization teams and relevant internal and external stakeholders to support franchise and enterprise goals.
  • Be accountable for resource requests, appropriate utilization, and delivery of adjusted net present value to the Late Stage Portfolio Committee.
  • Continually assess and evolve asset strategy in response to external dynamics, new opportunities, and disease-area strategy by evaluating and triggering value levers.
  • Propose and deliver indications, formulations, devices, diagnostics, digital tools, and an evidence-generation strategy in collaboration with commercial, development, technical, and other teams.
  • Lead the asset strategy and portfolio from research through to patients, serving as the single accountable leader to the Late Stage Portfolio Committee.
  • Meet product strategy milestones and financial targets through timely, on-target, and within-budget delivery.
  • Develop and lead a high-performing team to create and deliver asset strategy in a changing internal and external context.

Desired Qualifications

  • A marketing, business management, or life sciences discipline for the required Bachelor's degree.
  • An MD, PhD, other relevant graduate or postgraduate degree, or MBA, depending on the product lifecycle.
  • Therapeutic area experience.

About the Company

Roche

Global pharmaceuticals and diagnostics company

Roche is a global leader in pharmaceuticals and diagnostics. It develops medicines and diagnostic tools that help detect, monitor, and treat diseases, using research and biotechnology to drive new therapies and tests. Roche combines drug development with in-house diagnostic products to support personalized medicine, where treatments are tailored to individual patients based on test results. Its approach differs from many peers by integrating drug discovery with diagnostic capabilities and by expanding its research through strategic acquisitions (like Genentech) to strengthen its biotechnology and R&D capabilities. The company’s goal is to improve patient outcomes and healthcare worldwide by delivering reliable medicines, accurate diagnostic tests, and data-driven care.

Company size
1-10
Company stage
IPO
Headquarters
Basel, Switzerland
Founded
1896

Recently Posted Jobs

Explore more opportunities at Roche

See more jobs